GMRE
Income statement / Annual
Last year (2024), Global Medical REIT Inc.'s total revenue was $138.41 M,
a decrease of 1.79% from the previous year.
In 2024, Global Medical REIT Inc.'s net income was $6.63 M.
See Global Medical REIT Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$138.41 M |
$140.93 M |
$137.17 M |
$115.80 M |
$93.52 M |
$70.73 M |
$53.19 M |
$30.22 M |
$8.08 M |
$2.06 M |
| Cost of Revenue |
$29.25 M
|
$28.08 M
|
$25.19 M
|
$15.49 M
|
$10.87 M
|
$6.54 M
|
$3.72 M
|
$1.86 M
|
$1.43 M
|
$1.02 M
|
| Gross Profit |
$109.16 M
|
$112.85 M
|
$111.98 M
|
$100.32 M
|
$82.65 M
|
$64.19 M
|
$49.47 M
|
$28.36 M
|
$6.65 M
|
$1.04 M
|
| Gross Profit Ratio |
0.79
|
0.8
|
0.82
|
0.87
|
0.88
|
0.91
|
0.93
|
0.94
|
0.82
|
0.51
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.27
|
-$0.00
|
-$0.77
|
$0.00
|
| General & Administrative Expenses |
$21.12 M
|
$16.85 M
|
$16.55 M
|
$16.45 M
|
$29.96 M
|
$6.54 M
|
$9.96 M
|
$8.61 M
|
$5.73 M
|
$865.14 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.71 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$21.12 M
|
$16.85 M
|
$16.55 M
|
$16.45 M
|
$29.96 M
|
$14.25 M
|
$9.96 M
|
$8.61 M
|
$5.73 M
|
$865.14 K
|
| Other Expenses |
$55.36 M
|
$58.14 M
|
$56.72 M
|
$46.88 M
|
$52.69 M
|
$0.00
|
$17.27 M
|
$121.00 K
|
$130.78 K
|
$659.67 K
|
| Operating Expenses |
$76.48 M
|
$74.99 M
|
$73.27 M
|
$63.33 M
|
$82.65 M
|
$14.25 M
|
$27.23 M
|
$18.61 M
|
$8.10 M
|
$1.52 M
|
| Cost And Expenses |
$105.73 M
|
$103.07 M
|
$98.46 M
|
$78.82 M
|
$93.52 M
|
$20.79 M
|
$30.95 M
|
$20.47 M
|
$8.10 M
|
$1.52 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$28.69 M
|
$30.89 M
|
$25.23 M
|
$19.70 M
|
$18.68 M
|
$17.47 M
|
$14.98 M
|
$7.44 M
|
$4.14 M
|
$1.52 M
|
| Depreciation & Amortization |
$56.08 M
|
$59.01 M
|
$57.66 M
|
$47.31 M
|
$36.82 M
|
$23.76 M
|
$31.33 M
|
$23.00 M
|
$10.43 M
|
$659.67 K
|
| EBITDA |
$91.47 M |
$111.64 M |
$102.89 M |
$85.35 M |
$53.00 M |
$50.82 M |
$40.20 M |
$17.35 M |
$2.48 M |
$569.53 K |
| EBITDA Ratio |
0.66
|
0.79
|
0.75
|
0.74
|
0.57
|
0.72
|
0.76
|
0.57
|
0.31
|
0.28
|
| Operating Income Ratio |
0.24
|
0.27
|
0.28
|
0.32
|
0
|
0.71
|
0.42
|
0.24
|
-0.27
|
-0.74
|
| Total Other Income/Expenses Net |
-$25.99 M
|
-$16.13 M
|
-$18.72 M
|
-$18.65 M
|
-$2.50 M
|
-$40.35 M
|
-$7.68 M
|
-$9.96 M
|
-$6.33 M
|
-$2.13 M
|
| Income Before Tax |
$6.69 M
|
$21.73 M
|
$20.00 M
|
$18.34 M
|
-$2.50 M
|
$9.59 M
|
$14.56 M
|
-$87.00 K
|
-$6.35 M
|
-$1.61 M
|
| Income Before Tax Ratio |
0.05
|
0.15
|
0.15
|
0.16
|
-0.03
|
0.14
|
0.27
|
-0
|
-0.79
|
-0.78
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$49.00 K
|
$4.27 M
|
$1.52 M
|
| Net Income |
$6.63 M
|
$20.61 M
|
$19.14 M
|
$17.62 M
|
-$1.93 M
|
$9.23 M
|
$13.49 M
|
-$38.00 K
|
-$6.35 M
|
-$1.61 M
|
| Net Income Ratio |
0.05
|
0.15
|
0.14
|
0.15
|
-0.02
|
0.13
|
0.25
|
-0
|
-0.79
|
-0.78
|
| EPS |
0.31 |
5.75 |
-2 |
-0.855 |
-11.25 |
-6 |
15.25 |
-0.0475 |
-17 |
-161 |
| EPS Diluted |
0.31 |
5.75 |
-2 |
-0.855 |
-11.25 |
-6 |
15.25 |
-0.0475 |
-17 |
-161 |
| Weighted Average Shares Out |
$2.64 M
|
$2.62 M
|
$2.62 M
|
$2.43 M
|
$1.85 M
|
$1.35 M
|
$878.84 K
|
$784.68 K
|
$372.08 K
|
$10.00 K
|
| Weighted Average Shares Out Diluted |
$2.64 M
|
$2.62 M
|
$2.62 M
|
$2.43 M
|
$1.85 M
|
$1.35 M
|
$878.84 K
|
$784.68 K
|
$372.08 K
|
$10.00 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
